Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 9095-9104

  Malik, Manzoor Ahmad ^a   Zargar, Showkat Ali ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Gene polymorphisms; Meta analysis; NQO1 NQO2; PCR

Indexed keywords

ADENINE; CYTOSINE; GUANINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THYMINE;

ADULT; ARTICLE; ASIAN; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPEAN; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALE; NQO1 GENE; NQO2 GENE; POPULATION RESEARCH;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; QUINONE REDUCTASES; RISK;

EID: 84865131503     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1781-y     Document Type: Article

References (39)

1. Umar SB, Fleischer DE (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5:517-526
2. Malkan G, Mohandas KM (1997) Epidemiology of digestive cancers in India. I. General principles and esophageal cancer. Indian J Gastroenterol 16:98-102
3. Siddiqi M, Tricker AR, Preussmann R (1988) Formation of N-nitroso compounds under simulated gastric conditions from Kashmir foodstuffs. Cancer Lett 39:259-265
4. Khuroo MS, Zargar SA, Mahajan R et al (1992) High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33:11-15
5. Siddiqi M, Kumar R, Fazili Z et al (1992) Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 13:133-1331
6. Jaiswal AK (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36:1199-1207 (Pubitemid 38526313)
7. Traver RD, Siegel D, Beall HD et al (1997) Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 75:69-75 (Pubitemid 27007275)
8. Siegel D, McGuinness SM, Winski et al (1999) Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 9:113-121 (Pubitemid 29176730)
9. Misra V, Grondin A, Klamut HJ et al (2000) Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Br J Cancer 83:998-1002
10. Kuehl BL, Paterson JW, Peacock JW et al (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72:555-561
11. Nebert DW, Roe AL, Vandale SE et al (2002) NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4:62-70 (Pubitemid 44698580)
12. Kelsey KT, Ross D, Traver RD et al (1997) Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer 76:852-854 (Pubitemid 27401934)
13. Zhang JH, Li Y, Wang R et al (2003) NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol 9:1390-1393 (Pubitemid 36992319)
14. Zhang WC, Yin LH, Pu YP et al (2006) Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer. Zhonghua Yu Fang Yi Xue Za Zhi 40:324-327
15. di Martino E, Hardie LJ, Wild CP et al (2007) The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med 9:341-347 (Pubitemid 46956476)
16. Wiemels JL, Pagnamenta A, Taylor GM et al (1999) A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 59:4095-4099 (Pubitemid 29393583)
17. Smith MT, Wang Y, Kane E et al (2001) Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood 97:1422-1426 (Pubitemid 32183768)
18. Clairmont A, Sies H, Ramachandran S, Strange RC et al (1999) Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis 20:1235-1240 (Pubitemid 29341444)
19. Iida A, Sekine A, Saito S et al (2001) Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J Hum Genet 46:225-240 (Pubitemid 32435607)
20. Harada S, Fujii C, Hayashi A et al (2001) An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288:887-892 (Pubitemid 33140966)
21. Jamieson D, Wilson K, Pridgeon S et al (2007) NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism. Clin Cancer Res 13:1584-1590 (Pubitemid 46450451)
22. www. hapmap.ncbi.nlm.nih.gov
23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215
24. Malik MA, Zargar SA, Mittal B (2001) Role of NQO1 609C>T and NQO2 -3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. DNA Cell Biol 30:297-303
25. Comprehensive meta analysis version 2.0
26. Hamajima N, Matsuo K, Iwata H et al (2002) NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol 7:103-108 (Pubitemid 34538454)
27. Zhang J, Schulz WA, Li Y et al (2003) Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 24:905-909 (Pubitemid 36748907)
28. Sarbia M, Bitzer M, Siegel D et al. (2003) Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer 10:107(3):381-6 (Pubitemid 37266457)
29. von Rahden BH, Stein HJ, Langer R et al. (2005) C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer 20:113(3):506-8 (Pubitemid 40038723)
30. Marjani HA, Biramijamal F, Rakhshani N et al. (2010) Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran. Genet Mol Res 9:9(1):239-49
31. Zhang JH, Li Y, Wang R et al (2003) The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20(6):544-546 (Pubitemid 38017245)
32. Li Y, Zhang JH, Guo W et al (2004) Polymorphism of NAD(P)H dehydrogenase (quinone) 1 (NQO1) C609 T and risk of esophageal neoplasm. Zhonghua Liu Xing Bing Xue Za Zhi 25(8):731
33. Strassburg A, Strassburg CP, Manns MP et al (2002) Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue. Mol Pharmacol 61:320-325 (Pubitemid 34112806)
34. Siddiqi M, Preussmann R (1989) Esophageal cancer in Kashmir-an assessment. J Cancer Res Clin Oncol 115:111-117 (Pubitemid 19109367)
35. Iskander K, Jaiswal AK (2005) Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem Biol Interact 153(154):147-157 (Pubitemid 40797805)
36. Iskander K, Barrios RJ, Jaiswal AK (2009) NRH:quinone oxidoreductase 2-deficient mice are highly susceptible to radiation-induced B-cell lymphomas. Clin Cancer Res 15:1534-1542
37. Malik MA, Upadhyay R, Modi DR et al (2009) Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir valley. Arch Med Res 40:416-423
38. Malik MA, Upadhyay R, Mittal RD et al (2009) Role of xenobiotic- metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir valley. J Gastrointest Cancer 40:26-32
39. Li K, Ren YW, Wan Y et al (2012) SULT1A1 Arg213His polymorphism and susceptibility of environment-related cancers: a meta analysis of 5,915 cases and 7,900 controls. Mol Biol Rep 39:2597-605